ClinVar Miner

Submissions for variant NM_001164508.2(NEB):c.5370G>A (p.Glu1790=)

gnomAD frequency: 0.30371  dbSNP: rs10170273
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine,Mass General Brigham Personalized Medicine RCV000117761 SCV000269432 benign not specified 2014-11-26 criteria provided, single submitter clinical testing p.Glu1790Glu in exon 44 of NEB: This variant is not expected to have clinical si gnificance because it has been identified in 58% (2157/3720) of African American chromosomes by the NHLBI Exome Sequencing Project ( /EVS/; dbSNP rs10170273).
PreventionGenetics,PreventionGenetics RCV000117761 SCV000307361 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services,Illumina RCV000376756 SCV000416991 benign Nemaline myopathy 2 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
GeneDx RCV000117761 SCV000519521 benign not specified 2016-01-05 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000587923 SCV000697834 benign not provided 2017-02-27 criteria provided, single submitter clinical testing Variant summary: The NEB c.5370G>A (p.Glu1790Glu) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool, Mutation Taster, predicts a polymorphism outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may create an SF2/ASF ESE site. However, these predictions have yet to be confirmed by functional studies. This variant was found in 25704/85158 control chromosomes (4373 homozygotes) at a frequency of 0.3018389, which is approximately 85 times the estimated maximal expected allele frequency of a pathogenic NEB variant (0.0035355), suggesting this variant is likely a benign polymorphism. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. The variant of interest has not, to our knowledge, been reported in affected individuals via publications nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign.
Athena Diagnostics Inc RCV000587923 SCV001144726 benign not provided 2019-03-07 criteria provided, single submitter clinical testing
Invitae RCV000376756 SCV001716710 benign Nemaline myopathy 2 2021-12-19 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001542883 SCV001761280 benign Arthrogryposis multiplex congenita 6 2021-07-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000376756 SCV001761430 benign Nemaline myopathy 2 2021-07-10 criteria provided, single submitter clinical testing
Genetic Services Laboratory,University of Chicago RCV000117761 SCV000152018 likely benign not specified no assertion criteria provided clinical testing Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.
Natera, Inc. RCV000376756 SCV001453495 benign Nemaline myopathy 2 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.